CARLYE MCNAMARA: Open Payments
NPI 1558056804 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,103 in 88 payments from 23 companies in 2025. Trend: 2023 $2,536 · 2024 $2,814 · 2025 $2,103
Food & beverage: $2,103
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $319 |
| Sumitomo Pharma America, Inc. | 17 | $283 |
| Dendreon Pharmaceuticals LLC | 8 | $212 |
| UROGEN PHARMA, INC. | 10 | $168 |
| Calyxo, Inc. | 1 | $146 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $134 |
| PFIZER INC. | 5 | $130 |
| AstraZeneca Pharmaceuticals LP | 3 | $95 |
| ACCORD HEALTHCARE, INC. | 5 | $87 |
| Merck Sharp & Dohme LLC | 3 | $79 |
Products named: ERLEADA, PROVENGE, GEMTESA, LYNPARZA, CVAC ASPIRATION SYSTEM, Nubeqa, XTANDI, ORGOVYX.
Industry payments across OK — which companies pay providers there.
